This inventor holds 2 USPTO granted patents and 14 published patent applications and 2 EPO patents. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Junran Yang: Innovator in Pharmaceutical Chemistry
Introduction
Junran Yang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on oxopicolinamide derivatives. His research has implications for clinical treatments, showcasing his commitment to advancing medical science.
Latest Patents
Junran Yang holds a patent for a crystal form of an oxopicolinamide derivative and its preparation method. The patent details the provision of crystal forms A, B, C, D, E, and F of a compound, which exhibit good crystal stability and chemical stability. These properties enhance their potential for use in clinical treatment, marking a significant advancement in pharmaceutical applications.
Career Highlights
Throughout his career, Junran Yang has worked with prominent companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Jiangsu Hengrui Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the development of new medical treatments.
Collaborations
Junran Yang has collaborated with notable colleagues, including Likun Wang and Qiyun Shao. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research in their field.
Conclusion
Junran Yang's contributions to pharmaceutical chemistry through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the medical field positively, paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile